CN102240303A - 一种防治肠癌的复合益生菌的生产方法 - Google Patents
一种防治肠癌的复合益生菌的生产方法 Download PDFInfo
- Publication number
- CN102240303A CN102240303A CN2010101700192A CN201010170019A CN102240303A CN 102240303 A CN102240303 A CN 102240303A CN 2010101700192 A CN2010101700192 A CN 2010101700192A CN 201010170019 A CN201010170019 A CN 201010170019A CN 102240303 A CN102240303 A CN 102240303A
- Authority
- CN
- China
- Prior art keywords
- preventing
- intestinal cancer
- treating
- production method
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000005016 Intestinal Neoplasms Diseases 0.000 title claims abstract description 111
- 201000002313 intestinal cancer Diseases 0.000 title claims abstract description 111
- 239000006041 probiotic Substances 0.000 title claims abstract description 109
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 109
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 95
- 239000002131 composite material Substances 0.000 title abstract 3
- 241000894006 Bacteria Species 0.000 claims abstract description 183
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims abstract description 136
- 239000007788 liquid Substances 0.000 claims abstract description 106
- 239000001963 growth medium Substances 0.000 claims abstract description 94
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 64
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 64
- 230000000529 probiotic effect Effects 0.000 claims description 106
- 150000001875 compounds Chemical class 0.000 claims description 95
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 70
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 70
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 70
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 70
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 47
- 239000008103 glucose Substances 0.000 claims description 47
- 239000001888 Peptone Substances 0.000 claims description 35
- 108010080698 Peptones Proteins 0.000 claims description 35
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 35
- 229940041514 candida albicans extract Drugs 0.000 claims description 35
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 35
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 35
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 35
- 229940099596 manganese sulfate Drugs 0.000 claims description 35
- 239000011702 manganese sulphate Substances 0.000 claims description 35
- 235000007079 manganese sulphate Nutrition 0.000 claims description 35
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 35
- 235000019319 peptone Nutrition 0.000 claims description 35
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 35
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 35
- 239000011780 sodium chloride Substances 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000012138 yeast extract Substances 0.000 claims description 35
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 34
- 229920000053 polysorbate 80 Polymers 0.000 claims description 34
- 235000013336 milk Nutrition 0.000 claims description 24
- 239000008267 milk Substances 0.000 claims description 24
- 210000004080 milk Anatomy 0.000 claims description 24
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 24
- 239000002775 capsule Substances 0.000 claims description 15
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 12
- 238000004108 freeze drying Methods 0.000 claims description 12
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 12
- 230000000694 effects Effects 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 6
- 230000001580 bacterial effect Effects 0.000 abstract description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 abstract 2
- 238000009343 monoculture Methods 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 description 21
- 206010028980 Neoplasm Diseases 0.000 description 20
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 208000015634 Rectal Neoplasms Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 206010038038 rectal cancer Diseases 0.000 description 6
- 201000001275 rectum cancer Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 206010015856 Extrasystoles Diseases 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 208000003200 Adenoma Diseases 0.000 description 2
- 206010001233 Adenoma benign Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000193171 Clostridium butyricum Species 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000037062 Polyps Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 208000014081 polyp of colon Diseases 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 208000004804 Adenomatous Polyps Diseases 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 241000204294 Bacteroides stercoris Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000013370 mutualism Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000001986 peyer's patch Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000027272 reproductive process Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101700192A CN102240303B (zh) | 2010-05-12 | 2010-05-12 | 一种防治肠癌的复合益生菌的生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101700192A CN102240303B (zh) | 2010-05-12 | 2010-05-12 | 一种防治肠癌的复合益生菌的生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102240303A true CN102240303A (zh) | 2011-11-16 |
CN102240303B CN102240303B (zh) | 2013-01-09 |
Family
ID=44958663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101700192A Active CN102240303B (zh) | 2010-05-12 | 2010-05-12 | 一种防治肠癌的复合益生菌的生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102240303B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103602614A (zh) * | 2013-11-11 | 2014-02-26 | 南京曜动节能环保科技有限公司 | 一种复合微生态饲料添加剂的制备及应用 |
CN106222233A (zh) * | 2016-08-03 | 2016-12-14 | 四川剑南春(集团)有限责任公司 | 一种大曲发酵力检测培养基、制备方法及应用其检测大曲发酵力的方法 |
CN108676739A (zh) * | 2018-04-10 | 2018-10-19 | 凯磊(北京)科技有限公司 | 一种酪酸梭菌与嗜酸乳杆菌联合发酵制备复合益生菌制剂的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1928073A (zh) * | 2006-09-29 | 2007-03-14 | 杜灵广 | 酪酸菌加嗜酸乳杆菌联合发酵工艺 |
-
2010
- 2010-05-12 CN CN2010101700192A patent/CN102240303B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1928073A (zh) * | 2006-09-29 | 2007-03-14 | 杜灵广 | 酪酸菌加嗜酸乳杆菌联合发酵工艺 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103602614A (zh) * | 2013-11-11 | 2014-02-26 | 南京曜动节能环保科技有限公司 | 一种复合微生态饲料添加剂的制备及应用 |
CN103602614B (zh) * | 2013-11-11 | 2015-09-23 | 南京曜动节能环保科技有限公司 | 一种复合微生态饲料添加剂的制备及应用 |
CN106222233A (zh) * | 2016-08-03 | 2016-12-14 | 四川剑南春(集团)有限责任公司 | 一种大曲发酵力检测培养基、制备方法及应用其检测大曲发酵力的方法 |
CN108676739A (zh) * | 2018-04-10 | 2018-10-19 | 凯磊(北京)科技有限公司 | 一种酪酸梭菌与嗜酸乳杆菌联合发酵制备复合益生菌制剂的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102240303B (zh) | 2013-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103829092B (zh) | 用于治疗仔猪大肠杆菌性腹泻的中药组合物及饲料 | |
WO2019056404A1 (zh) | 脆弱拟杆菌在制备用于治疗和预防肿瘤的药物中的应用 | |
CN103637181A (zh) | 一种肿瘤患者食用的特殊膳食 | |
CN103478792B (zh) | 一种改善胃肠功能的固体饮料及其制备方法 | |
CN103689593A (zh) | 一种调理慢性浅表性胃炎的膳食 | |
CN103655637A (zh) | 胚芽乳酸杆菌cmu995菌株的新用途 | |
CN105039217A (zh) | 一种降血糖益生菌制剂及其制备方法 | |
CN104547521A (zh) | 一种用于增强畜禽免疫力的复合发酵型中药及其制备方法 | |
CN104187612A (zh) | 肾病全营养配方食品 | |
CN102240303B (zh) | 一种防治肠癌的复合益生菌的生产方法 | |
CN108402371A (zh) | 一种适合中老年便秘人群服用的益生元组合物 | |
CN101849969A (zh) | 产酪酸有益菌在制备防治重症疾病肠道屏障损伤及损伤后并发症制剂中的应用 | |
CN116622587B (zh) | 合成生物学方法制备的益生菌及其组合物和应用 | |
CN104523897B (zh) | 一种治疗仔猪流行性腹泻的灌肠药物组合物 | |
CN104547769A (zh) | 一种用于促进畜禽增重的复方发酵型中药及其制备方法 | |
CN104547770A (zh) | 一种促进畜禽生长的发酵中药及其制备方法 | |
CN109897795A (zh) | 一种微生物菌剂及其在防治便秘上的应用 | |
CN115300522A (zh) | 食窦魏斯氏菌d-2胞外多糖在抑制人结肠癌细胞中的应用 | |
CN103202861A (zh) | 酪酸梭菌、双歧杆菌二联活菌制剂与抗癌药物组合在制备治疗肠癌药物中的应用 | |
CN100406026C (zh) | 一种治疗慢性胃炎、胃癌的药物及其制备方法 | |
CN102726624A (zh) | 防治猪梭菌性肠炎的中药饲料添加剂 | |
CN104524162A (zh) | 一种用于提高畜禽抗应激的复合发酵型中药及其制备方法 | |
CN104873951A (zh) | 发酵型扶正解毒散的生产方法 | |
CN101537144B (zh) | 治疗消化***食道癌和胃癌的中药制剂 | |
CN104524154A (zh) | 一种用于畜禽止咳平喘的复合发酵型中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Zhengzhou jinbaihe Biological Engineering Co., Ltd. Assignor: Du Lingguang Contract record no.: 2010410000139 Denomination of invention: Production method of composite probiotics for preventing and treating intestinal cancer License type: Exclusive License Open date: 20111116 Record date: 20101009 |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160407 Address after: 450001, Zhengzhou province high tech Zone, Ruida Road, No. 96, No. Patentee after: Zhengzhou jinbaihe Biological Engineering Co., Ltd. Address before: 926 room 96, B District, 450001 Ruida Road, Zhengzhou hi tech Development Zone, Henan, China Patentee before: Du Lingguang |